CATEGORIES

Patient Zone

LATEST

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Mixing Covid Vaccines May Not Be a Great Idea, Research Shows

Research from, Oxford's Com-Cov study highlights how mixing vaccine brands during follow-up covid vaccinations increases the risk of mild to moderate side effects.

I’m Fully Vaccinated. Now What?

The CDC did not say that fully vaccinated people can stop wearing masks. In fact, they doubled down on mask wearing

Food Is the Prescription, and Food Pharmacies Could Be the Way to Better Health

Each mouthful of food may enhance and protect your health or damage it, and we now view food as a pharmaceutical.